Remove anebulo-pharmaceuticals-reports-second-quarter-fiscal-year-2023-financial-results-and-recent-updates
article thumbnail

 Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates

Medical Marijuana Program Connection

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid. Read More